Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Bioentrepreneur
  • Published:

Planning for the exit


As the biotech industry has matured, the exit process has evolved. Entrepreneurs need to build today's companies based on the new exit paradigm.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Author information

Authors and Affiliations


Corresponding author

Correspondence to Kenneth E Eheman Jr.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eheman, K. Planning for the exit. Nat Biotechnol 30, 132–134 (2012).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research